PDB17 ECONOMIC ASSESSMENT OF ADD-ON THERAPY WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH DYSLIPIDEMIA AND TYPE-2 DIABETES IN GERMANY AND SWEDEN
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67636-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)67636-X/fulltext
Title :
PDB17 ECONOMIC ASSESSMENT OF ADD-ON THERAPY WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH DYSLIPIDEMIA AND TYPE-2 DIABETES IN GERMANY AND SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67636-X&doi=10.1016/S1098-3015(10)67636-X
First page :
Section Title :
Open access? :
No
Section Order :
216